GGrantIndex
← Leaderboards

Carlos A. Camargo

Brigham And Women'S Hospital

$50,759,539
Attributed
$62,885,097
Total exposure
18
Grants
12
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $6.2M · FY200725
$10M$7.5M$5M$2.5M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$59,290,404 · 16
CDC$2,503,297 · 1
AHRQ$1,091,396 · 1

By mechanism

R01$22,233,869 · 8
U01$21,516,006 · 3
UH3$11,397,222 · 1
UG3$6,767,666 · 1
R21$732,792 · 2
K14$122,501 · 1

Top collaborators

Most similar at Brigham And Women'S Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Enrollment

Research focus

EnrollmentFundingSamplingAsthmaCohort StudiesUnited States National Institutes Of HealthFollow-UpCohortResearch PersonnelChildParentsHospitalizationHigh RiskChildhood AsthmaPositioning AttributeInnovationBronchiolitisDiagnosisInfantBaseMedical RecordsInterview6 Year OldCollaborations

Grant awards (68)

Host genetics, early-life microbiome, and childhood asthma: MARC-43 Boston$737,243
UH3 · FY2025 · OD · contact PI
Host genetics, early-life microbiome, and childhood asthma: MARC-43 Boston$832,707
UG3 · FY2024 · OD · contact PI
Host genetics, early-life microbiome, and childhood asthma: MARC-43 Boston$874,823
UG3 · FY2023 · OD · contact PI
Infant blood epigenome and risks of IgE sensitization, obesity, and asthma: MARC-35/43 cohorts$629,086
R01 · FY2023 · AI
Airway microbiome and age 6y asthma phenotypes in 2 diverse multicenter cohorts$2,259,392
UH3 · FY2022 · OD · contact PI
Nasal microRNA during bronchiolitis and age 6y asthma phenotypes: MARC-35 cohort$1,235,411
R01 · FY2021 · AI · contact PI
Airway microbiome and age 6y asthma phenotypes in 2 diverse multicenter cohorts$225,863
UH3 · FY2021 · OD · contact PI
Nasal microRNA during bronchiolitis and age 6y asthma phenotypes: MARC-35 cohort$85,967
R01 · FY2021 · AI · contact PI
Nasal microRNA during bronchiolitis and age 6y asthma phenotypes: MARC-35 cohort$1,485,833
R01 · FY2020 · AI · contact PI
Airway microbiome and age 6y asthma phenotypes in 2 diverse multicenter cohorts$1,368,451
UH3 · FY2020 · OD · contact PI
Nasal microRNA during bronchiolitis and age 6y asthma phenotypes: MARC-35 cohort$128,796
R01 · FY2020 · AI · contact PI
Airway microbiome and age 6y asthma phenotypes in 2 diverse multicenter cohorts$3,578,504
UH3 · FY2019 · OD · contact PI
Nasal microRNA during bronchiolitis and age 6y asthma phenotypes: MARC-35 cohort$1,572,951
R01 · FY2019 · AI · contact PI
Infant specific-IgE, rhinovirus-C bronchiolitis, and incident asthma in MARC-35$812,392
R01 · FY2019 · AI · contact PI
Comparative Effectiveness Research on Hospital Readmissions for COPD$249,231
R01 · FY2019 · HS · contact PI
Airway microbiome and age 6y asthma phenotypes in 2 diverse multicenter cohorts$3,227,769
UH3 · FY2018 · OD · contact PI
Nasal microRNA during bronchiolitis and age 6y asthma phenotypes: MARC-35 cohort$1,714,315
R01 · FY2018 · AI · contact PI
Infant specific-IgE, rhinovirus-C bronchiolitis, and incident asthma in MARC-35$807,406
R01 · FY2018 · AI · contact PI
Comparative Effectiveness Research on Hospital Readmissions for COPD$248,875
R01 · FY2018 · HS · contact PI
Airway microbiome and age 6y asthma phenotypes in 2 diverse multicenter cohorts$3,308,048
UG3 · FY2017 · OD · contact PI
Nasal microRNA during bronchiolitis and age 6y asthma phenotypes: MARC-35 cohort$1,786,162
R01 · FY2017 · AI · contact PI
Infant specific-IgE, rhinovirus-C bronchiolitis, and incident asthma in MARC-35$851,486
R01 · FY2017 · AI · contact PI
Comparative Effectiveness Research on Hospital Readmissions for COPD$218,228
R01 · FY2017 · HS · contact PI
Airway microbiome and age 6y asthma phenotypes in 2 diverse multicenter cohorts$1,752,088
UG3 · FY2016 · OD · contact PI
Infant specific-IgE, rhinovirus-C bronchiolitis, and incident asthma in MARC-35$900,476
R01 · FY2016 · AI · contact PI
Impact of Occupational Exposure to Disinfectant or Cleaning Agents on Asthma$478,040
R01 · FY2016 · OH · contact PI
Impact of Occupational Exposure to Disinfectant or Cleaning Agents on Asthma$278,299
R01 · FY2016 · OH · contact PI
Comparative Effectiveness Research on Hospital Readmissions for COPD$139,600
R01 · FY2016 · HS · contact PI
Prospective Cohort Study of Severe Bronchiolitis and Risk of Recurrent Wheezing$113,435
U01 · FY2016 · AI · contact PI
Infant specific-IgE, rhinovirus-C bronchiolitis, and incident asthma in MARC-35$864,174
R01 · FY2015 · AI · contact PI
Prospective Cohort Study of Severe Bronchiolitis and Risk of Recurrent Wheezing$788,590
U01 · FY2015 · AI · contact PI
Effects of vitamin D and omega-3 fatty acids on infectious diseases and hCAP18$783,256
R01 · FY2015 · AI · contact PI
Impact of Occupational Exposure to Disinfectant or Cleaning Agents on Asthma$597,450
R01 · FY2015 · OH · contact PI
Comparative Effectiveness Research on Hospital Readmissions for COPD$235,462
R01 · FY2015 · HS · contact PI
Prospective Cohort Study of Severe Bronchiolitis and Risk of Recurrent Wheezing$1,174,281
U01 · FY2014 · AI · contact PI
Effects of vitamin D and omega-3 fatty acids on infectious diseases and hCAP18$821,189
R01 · FY2014 · AI · contact PI
Impact of Occupational Exposure to Disinfectant or Cleaning Agents on Asthma$536,647
R01 · FY2014 · OH · contact PI
Emergency Department Safety Assessment and Follow-Up Evaluation (EDSAFE) Trial$1,594,969
U01 · FY2013 · MH
Prospective Cohort Study of Severe Bronchiolitis and Risk of Recurrent Wheezing$974,931
U01 · FY2013 · AI · contact PI
Effects of vitamin D and omega-3 fatty acids on infectious diseases and hCAP18$749,734
R01 · FY2013 · AI · contact PI
Impact of Occupational Exposure to Disinfectant or Cleaning Agents on Asthma$472,347
R01 · FY2013 · OH · contact PI
Emergency Department Safety Assessment and Follow-Up Evaluation (EDSAFE) Trial$162,875
U01 · FY2013 · MH
Impact of Occupational Exposure to Disinfectant or Cleaning Agents on Asthma$140,514
R01 · FY2013 · OH · contact PI
Emergency Department Safety Assessment and Follow-Up Evaluation (EDSAFE) Trial$78,993
U01 · FY2013 · MH
Emergency Department Safety Assessment and Follow-Up Evaluation (EDSAFE) Trial$2,717,641
U01 · FY2012 · MH
Prospective Cohort Study of Severe Bronchiolitis and Risk of Recurrent Wheezing$1,842,354
U01 · FY2012 · AI · contact PI
Effects of vitamin D and omega-3 fatty acids on infectious diseases and hCAP18$833,283
R01 · FY2012 · AI · contact PI
Emergency Department Safety Assessment and Follow-Up Evaluation (EDSAFE) Trial$2,611,585
U01 · FY2011 · MH
Prospective Cohort Study of Severe Bronchiolitis and Risk of Recurrent Wheezing$1,316,129
U01 · FY2011 · AI · contact PI
Effects of vitamin D and omega-3 fatty acids on infectious diseases and hCAP18$817,259
R01 · FY2011 · AI · contact PI
Emergency Department Safety Assessment and Follow-Up Evaluation (EDSAFE) Trial$2,397,396
U01 · FY2010 · MH
Prospective Multicenter Study of Bronchiolitis Admissions: Etiology & Disposition$796,878
U01 · FY2010 · AI · contact PI
Emergency Department Safety Assessment and Follow-Up Evaluation (EDSAFE) Trial$95,323
U01 · FY2010 · MH
Emergency Department Safety Assessment and Follow-Up Evaluation (EDSAFE) Trial$2,050,664
U01 · FY2009 · MH
Prospective Multicenter Study of Bronchiolitis Admissions: Etiology & Disposition$941,304
U01 · FY2009 · AI · contact PI
Prospective Multicenter Study of Bronchiolitis Admissions: Etiology & Disposition$883,729
U01 · FY2008 · AI · contact PI
Prospective Study of Dietary Factors, BMI, and Risk of Asthma in Children$349,825
R01 · FY2008 · HL · contact PI
Prospective Study of Diet, Physical Activity, BMI and Risk of Pulmonary Embolism$192,936
R21 · FY2008 · AG · contact PI
UTILITY OF HEMOGLOBIN A1C TO IDENTIFY ED PTS WITHOUT PREVOUSLY DIAG DIABETES$59,089
M01 · FY2008 · RR · contact PI
Prospective Multicenter Study of Bronchiolitis Admissions: Etiology & Disposition$974,929
U01 · FY2007 · AI · contact PI
Prospective Study of Dietary Factors, BMI, and Risk of Asthma in Children$393,175
R01 · FY2007 · HL · contact PI
Prospective Study of Diet, Physical Activity, BMI and Risk of Pulmonary Embolism$236,250
R21 · FY2007 · AG · contact PI
Hormonal and Inflammatory Markers in Adult-onset Asthma$303,606
R21 · FY2003 · AI
DIET AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE$339,000
R01 · FY2002 · HL
DIET AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE$339,000
R01 · FY2001 · HL
DIET AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE$339,000
R01 · FY2000 · HL
PROSPECTIVE STUDY OF DIETARY INTAKE AND ASTHMA$122,501
K14 · FY2000 · HL
MULTICENTER ASTHMA RESEARCH COLLABORATION$55,952
R03 · FY2000 · HL